Journal of Cancer Research and Therapeutics Close
 

Figure 3: Change in creatinine-derived estimated glomerular filtration rate (eGFR) from baseline during first 3 months of crizotinib therapy (pt: patient)

Figure 3: Change in creatinine-derived estimated glomerular filtration rate (eGFR) from baseline during first 3 months of crizotinib therapy (pt: patient)